As 2026 begins, the American surgical community is witnessing a pivotal transition toward the routine use of laboratory-grown tissue patches for complex wound care and cardiovascular repair. The integration of high-resolution cellular scaffolding into hospital-based biomanufacturing suites has moved from experimental pilot programs to formalized clinical pathways under new federal safety...
Russian 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Tiếng Việt